Cogent Biosciences News, Cogent Biosciences Quote, COGT Quote

Cogent Biosciences (NQ:COGT) Delayed: 32.97 +0.43 (1.32%)

Prev. Close

$32.54

Today 6M 1Y 5Y

Open

$33.07

52 Wk High

$5.57

52 Wk Low

$2.90

Day High

$33.64

Day Low

$32.94

P/E

149.86

EPS

$0.22

Volume

583,986

Friends, Peers and Foes (?): DCOM, ABBV, DYN, GPCR, NUVL (more...)

ALERTS | RSS

Sep 16, 2026 06:55 AM H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
Sep 15, 2026 08:01 AM FDA accepts Cogent Biosciences NDA for bezuclastinib in AdvSM
Sep 15, 2026 08:01 AM Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
Aug 27, 2026 04:18 PM Form 144 Cogent Biosciences, Inc. Filed by: Morris Arlene
Aug 20, 2026 06:53 AM H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
Aug 17, 2026 07:43 AM Cogent (COGT) PT Raised to $55 at Piper Sandler
Aug 13, 2026 04:12 PM Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Flynn James E
Aug 12, 2026 06:53 AM Cogent (COGT) PT Raised to $52 at Guggenheim
Aug 10, 2026 05:20 PM Form 8-K Cogent Biosciences, Inc. For: Aug 10
Aug 10, 2026 05:18 PM Form 424B5 Cogent Biosciences, Inc.

Entities mentioned with COGT

View All Entities